/Investor DB

APEX Ventures — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Robeautérobeaute.cominJan 2022✓ verified

Robeauté develops a medical microrobot designed to navigate the brain to diagnose and treat neurological conditions, aimed at neurosurgery applications.

Deep TechMedical DevicesRoboticsParis, FR

Bertrand Duplat(Co-founder & Chief Executive Officer)inJoana Cartocci(Co-founder & Chief Operating Officer)in

Co-investorsCherry VenturesKindred VenturesPluralLocalGlobeUrania Ventures

Lyfegenlyfegen.comin𝕏Sep 2022 · $8M

Lyfegen provides software for drug pricing, access, and rebate management, letting healthcare payers and pharmaceutical manufacturers identify pricing agreements, simulate their financial impact, and automate execution and adjudication.

Digital HealthHealthtechSaaSBasel, CH

Girisha Fernando(CEO & Founder)inMichel Mohler(CFO & Founder)Nico Julian Mros(CXO & Founder)inNico Mros

Co-investorsaMoonTX Ventures

Solvemedsolvemed.aiin𝕏Oct 2022

Solvemed develops a smartphone-based FDA-cleared medical device for pupil size and reactivity testing in neurological exams, eliminating the need for separate hardware.

AI & Machine LearningHealthtechMedical Devices

Michal Wlodarski, PhD(Founder)inHugo Chrost(Founder)in

Co-investorsCambridge Angels groupFf Venture CapitalSunfish PartnersSunfish PartnersPreface VenturesRheingau Founders+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.